Table 5.

Demographic characteristics of multiple sclerosis patients who interrupted glatiramer acetate treatment

Parameter	Total number of patients in the group	Number of patients who interrupted treatment in that group	Percentage of patients who interrupted treatment in that group
Gender
Male	289	22	8%
Female	842	91	11%
Age group (years)
9–20	85	9	11%
21–30	220	21	10%
31–40	333	33	10%
41–50	288	29	10%
51–60	168	20	12%
61–70	34	1	3%
>70	3	-	-